DE60209709D1 - Verfahren zur herstellung von chinazolinen - Google Patents
Verfahren zur herstellung von chinazolinenInfo
- Publication number
- DE60209709D1 DE60209709D1 DE60209709T DE60209709T DE60209709D1 DE 60209709 D1 DE60209709 D1 DE 60209709D1 DE 60209709 T DE60209709 T DE 60209709T DE 60209709 T DE60209709 T DE 60209709T DE 60209709 D1 DE60209709 D1 DE 60209709D1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- compound
- chinazolines
- preparation
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0112061.7A GB0112061D0 (en) | 2001-05-18 | 2001-05-18 | Process for the production of quinazolines |
| GB0112061 | 2001-05-18 | ||
| PCT/IB2002/001748 WO2002094815A1 (en) | 2001-05-18 | 2002-05-10 | Process for the production of quinazolines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60209709D1 true DE60209709D1 (de) | 2006-05-04 |
| DE60209709T2 DE60209709T2 (de) | 2006-10-12 |
Family
ID=9914812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60209709T Expired - Fee Related DE60209709T2 (de) | 2001-05-18 | 2002-05-10 | Verfahren zur herstellung von chinazolinen |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1387839B1 (de) |
| JP (1) | JP2004537519A (de) |
| AT (1) | ATE319707T1 (de) |
| BR (1) | BR0209861A (de) |
| CA (1) | CA2447233A1 (de) |
| DE (1) | DE60209709T2 (de) |
| ES (1) | ES2255615T3 (de) |
| GB (1) | GB0112061D0 (de) |
| MX (1) | MXPA03010504A (de) |
| WO (1) | WO2002094815A1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE635308A (de) * | 1962-07-23 | |||
| GB1477607A (en) * | 1975-03-13 | 1977-06-22 | Roche Products Ltd | 2-amidino-4-hydroxy-1,2,3,4-tetrahydroisoquinoline and salts thereof |
| GB8719378D0 (en) * | 1987-08-15 | 1987-09-23 | Pfizer Ltd | Antiarrythmic agents |
| GB9700504D0 (en) * | 1997-01-11 | 1997-02-26 | Pfizer Ltd | Pharmaceutical compounds |
-
2001
- 2001-05-18 GB GBGB0112061.7A patent/GB0112061D0/en not_active Ceased
-
2002
- 2002-05-10 DE DE60209709T patent/DE60209709T2/de not_active Expired - Fee Related
- 2002-05-10 WO PCT/IB2002/001748 patent/WO2002094815A1/en active IP Right Grant
- 2002-05-10 BR BR0209861-0A patent/BR0209861A/pt not_active IP Right Cessation
- 2002-05-10 EP EP02730579A patent/EP1387839B1/de not_active Expired - Lifetime
- 2002-05-10 CA CA002447233A patent/CA2447233A1/en not_active Abandoned
- 2002-05-10 ES ES02730579T patent/ES2255615T3/es not_active Expired - Lifetime
- 2002-05-10 JP JP2002591488A patent/JP2004537519A/ja not_active Withdrawn
- 2002-05-10 MX MXPA03010504A patent/MXPA03010504A/es active IP Right Grant
- 2002-05-10 AT AT02730579T patent/ATE319707T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03010504A (es) | 2004-03-02 |
| BR0209861A (pt) | 2004-06-15 |
| GB0112061D0 (en) | 2001-07-11 |
| DE60209709T2 (de) | 2006-10-12 |
| EP1387839B1 (de) | 2006-03-08 |
| ES2255615T3 (es) | 2006-07-01 |
| WO2002094815A1 (en) | 2002-11-28 |
| CA2447233A1 (en) | 2002-11-28 |
| ATE319707T1 (de) | 2006-03-15 |
| JP2004537519A (ja) | 2004-12-16 |
| EP1387839A1 (de) | 2004-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1108041T1 (el) | Αναστολεις της rho-κινασης | |
| EA200100411A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
| DK1200418T3 (da) | Nematodicide trifluorbutener | |
| HK1068626A1 (en) | Chemical compounds | |
| DE60228103D1 (de) | Chemische verbindungen | |
| CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
| WO2002076976A3 (en) | Rho-kinase inhibitors | |
| EA200300674A1 (ru) | Получение гетероциклических сульфонамидных ингибиторов бета-амилоида | |
| EA200100412A1 (ru) | Замещенные 3-цианохинолины в качестве ингибиторов протеинтирозинкиназ | |
| DE602004005323D1 (de) | Azidfreies verfahren zur herstellung von 1,2-diaminoverbindungen | |
| ES2243579T3 (es) | Derivados de pirazolopirideno. | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| MXPA04006041A (es) | Antivirales de piridoquinoxalina. | |
| SE0003476D0 (sv) | Compounds | |
| CY1105345T1 (el) | Φαινυλαλκινια | |
| DE60239842D1 (de) | Verfahren zur Herstellung von 10,11-dihydro-10-oxo-5h-dibenzoÄb,fÜazepin-5-carboxamid | |
| DE60224884D1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
| DE60222806D1 (de) | Verfahren zur herstellung von (1,4,5)-oxadiazepinderivaten | |
| DE60209709D1 (de) | Verfahren zur herstellung von chinazolinen | |
| EP1436279A4 (de) | Chemische verbindungen | |
| PT1276722E (pt) | Inibidores de naftamidina-uroquinase | |
| DE60230097D1 (de) | Verfahren zur herstellung von 1,5-diaminonaphthalinen | |
| DE60306361D1 (de) | Verfahren zur herstellung von benazeprilhydrochloride | |
| DE60143350D1 (de) | Verfahren zur herstellung von 1,3-dialkyl-2-imidazolidinon-derivaten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |